Accelerating Monoclonal Cell Line Development with Picodroplet Technology
Summary
This publication highlights an innovative approach for creating biomanufacturing-ready cell lines using Cyto-Mine® technology. By coupling microfluidic picodroplet workflows with integrated plate imaging, researchers achieved over 99% assurance of monoclonality, improving efficiency, and meeting stringent regulatory standards. Cyto-Mine®’s ability to screen, sort, and dispense single cells with high precision ensures a reliable and reproducible cell line development process, ideal for biotherapeutic applications.
Research highlights
- Study Title: Coupling picodroplet microfluidics with plate imaging for the rapid creation of biomanufacturing suitable cell lines with high probability and improved multi-step assurance of monoclonality.
- Authors: Pybus, L. P., Kalsi, D., Matthews, J. T., Hawke, E., Barber, N., Richer, R., Young, A., & Saunders, F. L.
- Published In: Biotechnol. J., 17, e2100357, 2022
- DOI: 10.1002/biot.202100357
Key findings
- High-throughput technology: Cyto-Mine® offers high-throughput capabilities that allow for the screening of a large number of single cells and finding the best ones for biomanufacturing.
- Precise dispensing and imaging: The precise dispensing and integrated imaging functionalities provide unique opportunities for improved monoclonality assurance.
- Reliable and reproducible workflows: The robust and efficient workflows ensure that users can consistently generate cell lines that meet regulatory requirements.
The Next Generation: Cyto-Mine® Chroma
Automate. Accelerate. Analyze millions of cells in a single day.
Think Cyto-Mine®, but supercharged, enabling multiplexing and greater assay flexibility to fit your needs. It means that you can examine vastly greater numbers of cells — and isolate the most valuable ones— with unparalleled precision.
Cyto-Mine® Chroma
Contact sales
